ENCell Co., Ltd. (KOSDAQ:456070)
South Korea · Delayed Price · Currency is KRW 6,310.00
-140.00 (-2.17%)
Aug 12, 2026, 1:05 PM KST
ENCell Market Cap
ENCell has a market cap or net worth of 71.14 billion as of August 11, 2026. Its market cap has decreased by -41.79% in one year.
Market Cap
71.14B
Enterprise Value
49.35B
Revenue
4.47B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,310.00
ChartMarket Cap Chart
Since August 23, 2024, ENCell's market cap has decreased from 160.82B to 71.14B, a decrease of -55.76%. That is a compound annual growth rate of -33.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 71.14B | -64.16% |
| Dec 30, 2025 | 198.50B | 7.25% |
| Dec 30, 2024 | 185.09B | 15.09% |
| Aug 23, 2024 | 160.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genexine | 123.70B |
| Vaxcell-Bio Therapeutics | 103.15B |
| MedPacto | 101.28B |
| iNtRON Biotechnology | 83.87B |
| Prestige BioPharma | 79.33B |
| Amicogen | 75.03B |
| CG Invites | 74.74B |
| ORIENT BIO | 63.08B |